Pharma Blog Watch

A A

Fallout From the Failed TeGenero Trial (The Pharm Voice)
In her entry, blogger Gloria Gamat writes about German company TeGenero, which recently folded in the wake of its ill-fated clinical trial for the monoclonal antibody drug TGN 1412.